*Review Process and Operations Modernization Support (RPOMS) New Cont

Forecast New Requirement Updated

Agency
Solicitation expected
Estimated value
$7,000,000 to $13,000,000
Set-aside
No set-aside

Forecast facts

Anticipated award
NAICS code
541519 Other Computer Related Services
Points of contact

Forecast details come from HHS's procurement forecast. Agencies' dates and values are estimates.

About this forecast

The Food and Drug Administration is procuring support for the Review Process and Operations Modernization Support (RPOMS) program, including architecture stewardship, implementation collaboration and integration services, development and coordination, and standards and harmonization across implementations. The effort supports the Center for Drug Evaluation and Research (CDER) and includes operations and maintenance support designed to expedite integrated product team delivery timelines, reduce system integration duplication, establish consistent development standards, and optimize user issue resolution. The solicitation is estimated to release on November 1, 2026, with award anticipated on April 1, 2027.

The estimated award value ranges from $7 million to $13 million. This is an unrestricted procurement under NAICS 541519 (Other Computer Related Services), with place of performance and contract term not specified in the forecast. Interested parties should contact the FDA Acquisition Liaison at cderacquisitions@fda.hhs.gov for additional details.

Forecast text

Provide support for architecture stewardship, implementation collaboration/integration services, development and coordination, standards and harmonization across implementations. Further, teams provide O&M support (as needed) to help expedite IPT delivery timelines, reduce duplication of system integration efforts, create consistent development standards, and optimize and streamline user issues resolution across CDER.

On GovTribe

Work this forecast

  • Track it in your pipeline
  • Find teaming partners
  • Similar forecasts
  • Ask GovTribe AI about this forecast